Insights
Defining the category, in the open.
Opinion and thought leadership from our scientists — on the gut-brain axis, precision modulation of the microbiome, the biology of keystone gut species, and what "evidence" should mean for functional ingredients.
We're in.
Trilliome at Vitafoods Europe 2026
Our CBO Tim Mak is on the floor in Barcelona this week with new efficacy data and an expanded portfolio of gut-brain bioactives.
We'll be in Rotterdam, 11-12 May
The window for fixing the gut-brain axis closes earlier than we thought
🚀 Trilliome is heading to Future Food Tech San Francisco
1,000 Followers in Under a Year — Thank You for Joining the Trilliome Journey
We just crossed 1,000 followers - thank you! At Trilliome, we’re programming the gut microbiome to boost anti-inflammatory, senescence-modulating, and neurotransmitter-supporting metabolites - turning deep biotech into scalable solutions for healthy aging.
Dubai, Microbiome & Longevity
Our co-founder Tim Mak is heading to Dubai to represent Trilliome—bridging Swiss biotech with Asia’s longevity market—before traveling on to Malaysia for Lunar New Year. He’ll attend key longevity and microbiome events and welcomes connections in Dubai.
Biotope Basecamp
Finalists at FI Startup Challenge
Trilliome Wins 1st Prize in EIT Food’s “Food as Medicine” Accelerator and Expands Global Recognition
Vitafood Asia
